The Newtonian: Issue #39, Winter 2026
January 22, 2026
Proud Sponsor of the Asian American Bar Association of New York Winter Soirée
January 26, 2026Firm Client AbelZeta Secures $630M Deal for Complete Global Rights to a CAR-T Cell Therapy
Congratulations to firm client AbelZeta on finalizing a $630 million deal with AstraZeneca, obtaining complete global rights to a CAR-T cell therapy targeting liver cancer and other solid tumors. Partners Michael Davitz and Jordan Garner were pleased to assist AbelZeta in closing this landmark transaction and supporting the development of next-generation oncology therapies.